Mammalian target of rapamycin is activated in association with myometrial proliferation during pregnancy

Endocrinology

Volumn 150, Issue 10, 2009, Pages 4672-4680

  Jaffer, Shabana ^a,b   Shynlova, Oksana ^a   Lye, Stephen ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; INITIATION FACTOR 4E BINDING PROTEIN 1; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; S6 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; IN VIVO STUDY; MUSCLE CELL; MYOMETRIUM; NONHUMAN; OVARIECTOMY; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; UTERUS CONTRACTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CARRIER PROTEINS; CELL PROLIFERATION; ENZYME ACTIVATION; ESTRADIOL; FEMALE; GENE EXPRESSION; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MYOCYTES, SMOOTH MUSCLE; MYOMETRIUM; OVARIECTOMY; PHOSPHOPROTEINS; PREGNANCY; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 70349315100     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0419     Document Type: Article

References (41)

1. Young RC 2007 Myocytes, myometrium, and uterine contractions. Ann NY Acad Sci 1101:72-84
2. Johansson B 1984 Different types of smooth muscle hypertrophy. Hypertension 6:III64 -III68 (Pubitemid 15170150)
3. Cole WC, Garfield RE 1989 Ultrastructure of the myometrium. In: Wynn RM, Jollie WP, eds. Biology of the uterus. New York: Plenum; 455-504
4. Douglas AJ, Clarke EW, Goldspink DF 1988 Influence of mechanical stretch on growth and protein turnover of rat uterus. Am J Physiol 254:E543-E548
5. Reynolds LP, Redmer DA 1992 Growth and microvascular development of the uterus during early pregnancy in ewes. Biol Reprod 47:698-708
6. Lye SJ 1999 Myometrial physiology and parturition. In: Rodeck CH, Whittle MJ, eds. Fetal medicine: basic science and clinical practice. Elsevier Health Sciences, London: 221-233
7. Shynlova O, Tsui P, Dorogin A, Langille BL, Lye SJ 2007 Insulin-like growth factors and their binding proteins define specific phases of myometrial differentiation during pregnancy in the rat. Biol Reprod 76:571-578 (Pubitemid 46466513)
8. Jensen EV, DeSombre ER 1972 Mechanism of action of the female sex hormones. Annu Rev Biochem 41:203-230
9. Clark JH, Peck Jr EJ 1979 Female sex steroids: receptors and function. Monogr Endocrinol 14:I-XII, 1-245
10. Lye SJ, Tsui P, Dong X, Mitchell J, Dorogin A, McPhee D, Oldenhoff A, Langille BL, Challis JRG, Shynlova O 2006 Myometrial programming: a new concept underlying the regulation of myometrial function during pregnancy. In: Petraglia F, Strauss JF, Gabbe SG, Weiss G, eds. Preterm birth: mechanisms, mediators, prediction, prevention and interventions. Essex, UK: Informa Healthcare UK; 3-18
11. Murphy LJ, Friesen HG 1988 Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat. Endocrinology 122:325-332
12. Rajkumar K, Dheen T, Krsek M, Murphy LJ 1996 Impaired estrogen action in the uterus of insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 137:1258-1264 (Pubitemid 26095239)
13. Yin XJ, Wang G, Khan-Dawood FS 2007 Requirements of phosphatidylinositol- 3 kinase and mammalian target of rapamycin for estrogen-induced proliferation in uterine leiomyoma- and myometrium-derived cell lines. Am J Obstet Gynecol 196:176.e171-e175 (Pubitemid 46251376)
14. Gelfant S 1955 Uterine Growth following stimulation by estrogen and inhibition by aminopterin and nitrogen mustard. J Exp Zool 128:219-257
15. Gielen SC, Santegoets LA, Kühne LC, Van Ijcken WF, Boers-Sijmons B, Hanifi-Moghaddam P, Helmerhorst TJ, Blok LJ, Burger CW 2007 Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathway. Reprod Sci 14:646-654 (Pubitemid 351903573)
16. Le Roith D 2003 The insulin-like growth factor system. Exp Diab Res 4:205-212
17. Lye SJ, Mitchell J, Nashman N, Oldenhof A, Ou R, Shynlova O, Langille L 2001 Role of mechanical signals in the onset of term and preterm labor. Front Horm Res 27:165-178 (Pubitemid 33816371)
18. Klotz DM, Hewitt SC, Ciana P, Raviscioni M, Lindzey JK, Foley J, Maggi A, DiAugustine RP, Korach KS 2002 Requirement of estrogen receptor-α in insulin-like growth factor-1 (IGF-I)-induced uterine responses and in vivo evidence for IGF-I/estrogen receptor crosstalk. J Biol Chem 277:8531-8537
19. Sahlin L, Norstedt G, Eriksson H 1994 Estrogen regulation of the estrogen receptor and insulinlike growth factor-I in the rat uterus: a potential coupling between effects of estrogen and IGF-I. Steroids 59:421-430 (Pubitemid 24226901)
20. Gielen SC, Hanekamp EE, Blok LJ, Huikeshoven FJ, Burger CW 2005 Steroid-modulated proliferation of human endometrial carcinoma cell lines: any role for insulin-like growth factor signaling? J Soc Gynecol Investig 12:58-64
21. Zhang Z, Kumar R, Santen RJ, Song RX 2004 The role of adapter protein Shc in estrogen non-genomic action. Steroids 69:523-529 (Pubitemid 39013482)
22. Wullschleger S, Loewith R, Hall MN 2006 TOR signaling in growth and metabolism. Cell 124:471-484
23. Proud CG 2004 mTOR-mediated regulation of translation factors by amino acids. Biochem Biophys Res Commun 313:429-436 (Pubitemid 37543604)
24. Bjornsti MA, Houghton PJ 2004 The TOR pathway: a target for cancer therapy. Nat Rev Cancer 4:335-348 (Pubitemid 38579480)
25. Fingar DC, Blenis J 2004 Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151-3171 (Pubitemid 38638827)
26. Lee CH, Inoki K, Guan KL 2007 mTOR pathway as a target in tissue hypertrophy. Annu Rev Pharmacol Toxicol 47:443-467 (Pubitemid 46272135)
27. Gingras AC, Raught B, Sonenberg N 1999 eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913-963 (Pubitemid 29449212)
28. Shioi T, McMullen JR, Tarnavski O, Converso K, Sherwood MC, Manning WJ, Izumo S 2003 Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107:1664-1670 (Pubitemid 36397337)
29. Proud CG 2004 Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy. Cardiovasc Res 63:403-413
30. Gerdes J, Schwab U, Lemke H, Stein H 1983 Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13-20 (Pubitemid 13179545)
31. Marx SO, Jayaraman T, Go LO, Marks AR 1995 Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76:412-417
32. Mauro L, Salerno M, Panno ML, Bellizzi D, Sisci D, Miglietta A, Surmacz E, Andò S 2001 Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells. Biochem Biophys Res Commun 288:685-689 (Pubitemid 33030084)
33. Shamji AF, Nghiem P, Schreiber SL 2003 Integration of growth factor and nutrient signaling: implications for cancer biology. Mol Cell 12:271-280 (Pubitemid 37238914)
34. Keith CT, Schreiber SL 1995 PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 270:50-51
35. Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J 2004 Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci USA 101:13489-13494 (Pubitemid 39238430)
36. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP 2005 Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosisandcancer pathogenesis. Cell 121:179-193 (Pubitemid 40546387)
37. Hay N, Sonenberg N 2004 Upstream and downstream of mTOR. Genes Dev 18:1926-1945
38. Abraham RT, Wiederrecht GJ 1996 Immunopharmacology of rapamycin. Annu Rev Immunol 14:483-510
39. Boyer D, Quintanilla R, Lee-Fruman KK 2008 Regulation of catalytic activity of S6 kinase 2 during cell cycle. Mol Cell Biochem 307:59-64 (Pubitemid 350238647)
40. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DB, Schomberg DW, Smith EP 1996 Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 51:159-186; discussion 186-188 (Pubitemid 126476613)
41. Suzuki A, Urushitani H, Watanabe H, Sato T, Iguchi T, Kobayashi T, Ohta Y 2007 Comparison of estrogen responsive genes in the mouse uterus, vagina and mammary gland. J Vet Med Sci 69:725-731 (Pubitemid 47281489)